An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy

PURPOSE: This pilot study assessed the efficacy of 12 weeks of daily treatment with a vaginal gel based on a water-based cellulose gel in reducing the severity of moderate–severe symptoms of vulvovaginal atrophy (VVA) and followed adverse events in female breast cancer patients undergoing treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonasson, Aino Fianu, Åstrom, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242146/
https://www.ncbi.nlm.nih.gov/pubmed/34234580
http://dx.doi.org/10.2147/MDER.S303234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242146/
https://www.ncbi.nlm.nih.gov/pubmed/34234580
http://dx.doi.org/10.2147/MDER.S303234

Ejemplares similares